BIOLASE Revenue

BIOLASE had revenue of $10.85M in the quarter ending September 30, 2024, a decrease of -0.65%. This brings the company's revenue in the last twelve months to $46.03M, down -7.44% year-over-year. In the year 2023, BIOLASE had annual revenue of $49.16M with 1.45% growth.

Revenue (ttm)

46.03M

Revenue Growth

-7.44%

P/S Ratio

0.00

Revenue / Employee

293.16K

Employees

157

Market Cap

274.48K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	49.16M	702.00K	1.45%
Dec 31, 2022	48.46M	9.27M	23.67%
Dec 31, 2021	39.19M	16.41M	72.03%
Dec 31, 2020	22.78M	-15.02M	-39.73%
Dec 31, 2019	37.80M	-8.36M	-18.10%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sandoz Group AG	10.11B
Telix Pharmaceuticals Limited	430.80M
Elekta AB (publ)	1.66B
Ryman Healthcare Limited	458.44M
Verano Holdings Corp.	897.57M
Vireo Growth Inc.	98.53M
Medexus Pharmaceuticals Inc.	104.76M

Revenue Rankings